We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

BLOOM:PSEBloomberry Resorts Corporation Analysis

Data as of 2026-08-27 - not real-time

$217.65

Latest Price

9/10Risk

Risk Level: High

Executive Summary

Bloom Energy Corporation trades at $217.65, with its moving averages tangled rather than clearly stacked — a neutral trend structure. The last 30 days have gained 5.3%. Relative strength is 49.2 — neutral — and the MACD signal is bullish. Recent trading has carved out support near $185.93 and resistance around $253.31.
Multiples put this in overvalued territory: 286.4 times earnings against the sector's 29.6. Consensus targets land 26.4% above where the shares trade now. Revenue is growing at 165.5% on a 7.9% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 120.2%, a beta of 4.37 and a maximum drawdown of 52.7%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 1/10 conviction.

Top Market Events

Bloom Energy posted blowout second-quarter results.Business Wire27dShareholder Alert - Robbins LLP Informs Investors of the Bloom Energy Corporation Class Action...Yahoo Finance29dBloom Energy Corp BE Q2 2026 Earnings Call Highlights: Record Revenue and Strategic ExpansionThe above...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 188.15
  • MACD momentum is positive
  • 30-day price change of +5.3%

Medium Term

1–3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 286.4 versus sector average of 29.6
  • Trading above the 200-day average of 188.15
  • Analyst targets imply +26.4% versus the current price

Long Term

> 3 years
Neutral
Model confidence: 1/10

Key Factors

  • P/E of 286.4 versus sector average of 29.6
  • Analyst targets imply +26.4% versus the current price
  • Revenue growth of +165.5%

Key Metrics & Analysis

Financial Health

Revenue Growth165.50%
Profit Margin7.87%
P/E Ratio286.4
ROE22.21%
ROA5.60%
Debt/Equity171.58
P/B Ratio39.6
Op. Cash Flow$737.8M
Free Cash Flow$531.6M
Industry P/E29.6

Technical Analysis

TrendNeutral
RSI49.2
Support$185.93
Resistance$253.31
MA 20$218.45
MA 50$238.09
MA 200$188.15
MACDBullish
VolumeDecreasing
Fear & Greed Index94.63

Valuation

Fair Value$63.19
Target Price$275.08
Upside/Downside26.39%
GradeOvervalued
TypeGrowth

Risk Assessment

Beta4.37
Volatility120.16%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.